Greater preservation of SARS-CoV-2 neutralising antibody responses following the ChAdOx1-S (AZD1222) vaccine compared to mRNA vaccines in haematopoietic cell transplant recipients

Helen Parry

doi:10.1111/19874

Greater preservation of SARS-CoV-2 neutralising antibody responses following the ChAdOx1-S (AZD1222) vaccine compared to mRNA vaccines in haematopoietic cell transplant recipients

Immunology and Immunotherapy

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	British Journal of Haematology
DOIs	https://doi.org/10.1111/19874
Publication status	Accepted/In press - 4 Nov 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/19874Licence: None: All rights reserved

Cite this

@article{877974196dc8486b9dbf26bc9b96340a,

title = "Greater preservation of SARS-CoV-2 neutralising antibody responses following the ChAdOx1-S (AZD1222) vaccine compared to mRNA vaccines in haematopoietic cell transplant recipients",

author = "Helen Parry",

year = "2024",

month = nov,

day = "4",

doi = "10.1111/19874",

language = "English",

journal = "British Journal of Haematology",

issn = "0007-1048",

publisher = "Wiley",

}

TY - JOUR

T1 - Greater preservation of SARS-CoV-2 neutralising antibody responses following the ChAdOx1-S (AZD1222) vaccine compared to mRNA vaccines in haematopoietic cell transplant recipients

AU - Parry, Helen

PY - 2024/11/4

Y1 - 2024/11/4

U2 - 10.1111/19874

DO - 10.1111/19874

M3 - Article

SN - 0007-1048

JO - British Journal of Haematology

JF - British Journal of Haematology

ER -